MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...

Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech sector more than pharma? We asked Seeking Alpha analysts Stephen Ayers ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug development and research, commercial strategy, and pharmaceutical ...

January kicked off the year with a flurry of notable leadership transitions across the pharmaceutical and biotechnology sectors. Here is a detailed look at the latest hires and departures.

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number of changes at the big pharmas, which may have slipped under your radar ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Die große Frage: Kann Heidelberg Pharma den positiven Trend fortsetzen? Viel hängt davon ab, wann erste Zwischendaten aus der HDP-102-Studie veröffentlicht werden. Bis dahin dürfte der Titel ...

By Michael Levenson 23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company ...

The workforce reduction will be complete by July 14. Story June 10 - Recursion Pharmaceuticals: The AI biotech is laying off a fifth of its workforce in connection with a previously announced ...

Two Itochu Corp. units are expanding into the business of luring more foreign drug companies to Japan, in a bid to help them ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...